Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Dixon Tech shares jump 4% on govt nod to form JV with Vivo. What are experts saying?
Dixon Technologies' shares rose significantly after Vivo Mobile India secured government approval for a joint venture. This partnership will focus on manufacturing smartphones for Vivo within India. Experts foresee substantial production increases and strengthened market leadership for Dixon. The joint venture is expected to commence operations by September 2026. Dixon's strong financial metrics and policy support underpin its positive outlook.

Dixon Tech Shares Rally Nearly 3% After Long-Awaited Vivo JV Approval — Should You Buy?
The joint venture will engage in original equiment manufacturing (OEM) for smartphones. Dixon Tech holds 51% stake in the JV with Vivo, as per the filing.

Dixon Tech Shares In Focus After Long-Awaited Vivo JV Approval; Motilal Oswal Remains Bullish — Check Revised Target Price
Dixon has received the long-pending PN3 approval for its 51:49 JV with Vivo and Motilal Oswal expects this JV to enhance the company's manufacturing capabilities and strengthen its market share and positioning in the Android smartphone market in India.

Dixon Tech Remains Top Pick For JP Morgan After Vivo JV Approval; 39% Upside Seen — Check Target Price
JPMorgan raised its Dixon Technologies target price to Rs 16,700 after the Vivo JV approval, implying 39% upside and triggering sharp revenue and earnings upgrades.

Dixon Tech 'bulls' raise share price target past ₹16,000 after Vivo JV approval; check key levels
Analysts believe the JV with Vivo will strengthen Dixon's manufacturing capabilities and enhance its market position in India's Android smartphone segment. The approval also removes a long-standing overhang on the stock, as the JV is expected to start contributing incremental volumes from Q3FY27.

Govt Clears Dixon Tech's JV With Vivo For Smartphone Manufacturing
Dixon Tech holds 51% stake in the JV.

Market ends higher: 3 factors that helped Sensex, Nifty snap two-day losing streak
Bharti Airtel, HDFC Bank and Sun Pharma were the biggest contributors to the Nifty's gains. The Nifty Bank index climbed 510 points to 57,252, while the Midcap index outperformed, rising 844 points to 62,167.
Sensex Today Rallies 541 Points | Nifty Above 24,000 | Bharti Airtel & Sun Pharma Top Gainers - Equitymaster
Sensex Today Rallies 541 Points | Nifty Above 24,000 | Bharti Airtel & Sun Pharma Top GainersEquitymaster
Sensex Today Rallies 541 Points | Nifty Above 24,000 | Bharti Airtel & Sun Pharma Top Gainers - Equitymaster
Sensex Today Rallies 541 Points | Nifty Above 24,000 | Bharti Airtel & Sun Pharma Top GainersEquitymaster
10 microcap stocks rally up to 430% in CY26; 5 turn multibaggers: Here’s FII and MF exposure
Microcap stocks delivered stellar CY26 gains, with several companies rallying over 50%. Sterlite Technologies, MTAR Technologies and others emerged as multibaggers, attracting significant FII and mutual fund interest.
MF Picks: 13 stocks surge up to 230% in just 3 months; 3 turn multibaggers
Thirteen BSE 500 stocks surged 60%–230% in just over three months after mutual funds increased their holdings in the March 2026 quarter, with HFCL, Cemindia Projects and Aditya Infotech emerging as multibaggers.

Top Gainers & Losers on 6 July: Swan Corp, Zen Tech, HFCL, HDFC Bank, Thermax, Hitachi Energy among top gainers
Indian stock markets rose on July 6, with benchmark indices gaining over 0.60%. The Nifty 50 closed 0.66% higher at 24,420, while Sensex advanced 0.67% to 78,236. HDFC Bank and Axis Bank drove gains, while Nifty Realty led sectoral increases with a 2% rise.